RxDoctor Payments Data

Stacy Veldhuizen Mickey, MD

Family Medicine · Mesa, AZNPI 1760449490

Payments from drug & device makers

$782in general payments, 2019–2025

Across 56 payments — averaging $13.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$188
  • Takeda Pharmaceuticals U.S.A., Inc.$145
  • Boehringer Ingelheim$108
  • Amgen$87
  • AbbVie$77
  • Lilly USA, LLC$53
  • plus $124 from 7 others

What the payments were for

  • Food & beverage$782100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$782 in reported general payments places this provider in the 65th percentile of 2,099 family medicine providers in Arizona.

See all family medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$153,403
Medicare patients
453
Services billed
2,137

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban47$64,784
MounjaroTirzepatide48$56,597
OzempicSemaglutide29$50,702
JardianceEmpagliflozin27$41,920
TrulicityDulaglutide18$40,574
FarxigaDapagliflozin Propanediol13$20,259
XareltoRivaroxaban11$13,626
Breztri AerosphereBudesonide/Glycopyr/Formoterol19$11,578
Tresiba Flextouch U-100Insulin Degludec13$8,401
Atorvastatin Calcium466$3,654
Levothyroxine Sodium373$3,226
Metoprolol Succinate163$2,386
Losartan Potassium233$2,141
Bupropion XlBupropion Hcl63$1,957
SynthroidLevothyroxine Sodium24$1,674

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$53$97,17166 claims
Novo NordiskOzempic$188$50,70229 claims
Boehringer IngelheimJardiance$108$41,92027 claims
AstraZenecaFarxiga, Breztri Aerosphere$43$31,83832 claims
Johnson & JohnsonXarelto$11$13,62611 claims
AbbVieSynthroid$77$1,67424 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,099 family medicine providers in Arizona.

Other family medicine in Mesa

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →